BMY vs GTLS · P/E 17, rev $24.46B vs rev $4.26B
Bristol-Myers Squibb Company (BMY) versus Chart Industries Inc (GTLS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Chart Industries Inc (GTLS) is a specialty industrial machinery company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported GTLS revenue for 2025-12-31 was $4.26B. Net income was $40.7M. Revenue was up 2.5% from 2024-12-31 to 2025-12-31. GTLS currently screens at market cap $9.90B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. GTLS currently screens at market cap $9.90B.
Not investment advice. Open the BMY and GTLS stock pages for the full models.
Not investment advice.